T cell-mediated hypersensitivity to quinolones: Mechanisms and cross-reactivity

Clinical and Experimental Allergy

Volumn 36, Issue 1, 2006, Pages 59-69

  Schmid, D A ^a   Depta, J P H ^a   Pichler, W J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cross reactivity; Delayed hypersensitivity drug reaction; Drug reactive T cells; p i concept; Quinolone

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CIPROFLOXACIN; ENOXACIN; GAMMA GLUTAMYLTRANSFERASE; GLUTARALDEHYDE; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PIPEMIDIC ACID; QUINOLONE DERIVATIVE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ANTIGEN PRESENTING CELL; ARTICLE; CELL ASSAY; CELL CLONE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; FLUSHING; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MACULOPAPULAR RASH; MAJOR HISTOCOMPATIBILITY COMPLEX; PATCH TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKIN DISEASE; T LYMPHOCYTE; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGEN-PRESENTING CELLS; AZA COMPOUNDS; CELL PROLIFERATION; CELLS, CULTURED; CIPROFLOXACIN; CLONE CELLS; CROSS REACTIONS; DRUG HYPERSENSITIVITY; ENOXACIN; FEMALE; FLUOROQUINOLONES; HUMANS; HYPERSENSITIVITY, DELAYED; MIDDLE AGED; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PATCH TESTS; PIPEMIDIC ACID; QUINOLINES; QUINOLONES; T-LYMPHOCYTES;

EID: 33645034953     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02402.x     Document Type: Article

References (44)

1. Hooper DC Wolfson JS. Mode of action of the new quinolones new data Eur J Clin Microbiol Infect Dis 1991 10 223 31
2. Paton JH Reeves DS. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use Drugs 1988 36 193 228
3. Larouche G. Les quinolones des années soixante à aujourd'hui Pharmactuel 2001 34 40 6
4. Ronnau AC Sachs B von Schmiedeberg S et al Cutaneous adverse reaction to ciprofloxacin demonstration of specific lymphocyte proliferation and cross-reactivity to ofloxacin in vitro Acta Derm Venereol 1997 77 285 8
5. Davis H McGoodwin E Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin Ann Intern Med 1989 111 1041 3
6. Manfredi M Severino M Testi S et al Detection of specific IgE to quinolones J Allergy Clin Immunol 2004 113 155 60
7. Roujeau JC Stern RS. Severe adverse cutaneous reactions to drugs N Engl J Med 1994 331 1272 85
8. Fernandez-Rivas M. Fixed drug eruption (FDE) caused by norfloxacin Allergy 1997 52 477 8
9. Alonso MD Martin JA Quirce S Davila I Lezaun A SanchezCano M. Fixed eruption caused by ciprofloxacin with cross-sensitivity to norfloxacin Allergy 1993 48 296 7
10. Tsuda S Kato K Karashima T Inou Y Sasai Y. Toxic pustuloderma induced by ofloxacin Acta Derm Venereol 1993 73 382 4
11. Kawada A Hiruma M Morimoto K Ishibashi A Banba H. Fixed drug eruption induced by ciprofloxacin followed by ofloxacin Contact Dermatitis 1994 31 182 3
12. Pichler WJ. Delayed drug hypersensitivity reactions Ann Intern Med 2003 139 683 93
13. von Greyerz S Burkhart C Pichler WJ. Molecular basis of drug recognition by specific T-cell receptors Int Arch Allergy Immunol 1999 119 173 80
14. Schnyder B Mauri-Hellweg D Zanni M Bettens F Pichler WJ. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones J Clin Invest 1997 100 136 41
15. Zanni MP von Greyerz S Schnyder B et al HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes J Clin Invest 1998 102 1591 8
16. Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors the p-i concept Curr Opin Allergy Clin Immunol 2002 2 301 5
17. Britschgi M Steiner UC Schmid S et al T-cell involvement in drug-induced acute generalized exanthematous pustulosis J Clin Invest 2001 107 1433 41
18. Schnyder B Frutig K Mauri-Hellweg D Limat A Yawalkar N Pichler WJ. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction Clin Exp Allergy 1998 28 1412 7
19. Barbaud A Reichert-Penetrat S Tréchot P. The use of skin testing in the investigation of cutaneous adverse drug reactions Br J Dermatol 1998 139 49 58
20. Pichler WJ Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity Allergy 2004 59 809 20
21. Davila I Diez ML Quirce S Fraj J De La Hoz B Lazaro M. Cross-reactivity between quinolones. Report of three cases Allergy 1993 48 388 90
22. Hug K Yawalkar N Helbling A Pichler WJ. Scratch-patch and patch testing in drug allergy - an assessment of specificity J Invest Allergol Clin Immunol 2003 13 12 9
23. Wilkinson DS Fregert S Magnusson B et al Terminology of contact dermatitis Acta Derm Venereol 1970 50 287 92
24. Wyss-Coray T Gallati H Pracht I et al Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones Eur J Immunol 1993 23 3350 7
25. Zanni MP Mauri-Hellweg D Brander C et al Characterization of lidocaine-specific T cells J Immunol 1997 158 1139 48
26. Genevee C Diu A Nierat J et al An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction Eur J Immunol 1992 22 1261 9
27. Mauri-Hellweg D Bettens F Mauri D Brander C Hunziker T Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine J Immunol 1995 155 462 72
28. Shimonkevitz R Kappler J Marrack P Grey H. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing J Exp Med 1983 158 303 16
29. Forsgren A Schlossman SF Tedder TF. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro Antimicrob Agents Chemother 1987 31 768 73
30. Nasorri F Sebastiani S Mariani V et al Activation of nickel-specific CD4+ T lymphocytes in the absence of professional antigen-presenting cells J Invest Dermatol 2002 118 172 9
31. Kuechler PC Britschgi M Schmid S Hari Y Grabscheid B Pichler WJ. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies Allergy 2004 59 613 22
32. Schnyder B Burkhart C Schnyder-Frutig K et al Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals J Immunol 2000 164 6647 54
33. Campi P Pichler WJ. Quinolone hypersensitivity Curr Opin Allergy Clin Immunol 2003 3 275 81
34. Naisbitt DJ Gordon SF Pirmohamed M et al Antigenicity and immunogenicity of sulphamethoxazole demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo Br J Pharmacol 2001 133 295 305
35. Padovan E Mauri-Hellweg D Pichler WJ Weltzien HU. T cell recognition of penicillin G structural features determining antigenic specificity Eur J Immunol 1996 26 42 8
36. von Greyerz S Zanni MP Frutig K Schnyder B Burkhart C Pichler WJ. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human αβ+ T cell clones J Immunol 1999 162 595 602
37. Mauri-Hellweg D Zanni M Frei E et al Cross-reactivity of T cell lines and clones to beta-lactam antibiotics J Immunol 1996 157 1071 109
38. Naisbitt DJ Britschgi M Wong G et al Hypersensitivity reactions to carbamazepine characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones Mol Pharmacol 2003 63 732 41
39. Naisbitt DJ Farrell J Wong G et al Characterization of drug-specific T cells in lamotrigine hypersensitivity J Allergy Clin Immunol 2003 111 1393 403
40. Beermann D. Metabolism of ciprofloxacin in man Curr Clin Pract Series 1985 34 141 6
41. Reilly TP Lash LH Doll MA Hein DW Woster PM Svensson CG. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions J Invest Dermatol 2000 114 1164 73
42. Nyfeler B Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy sensitivity and specificity Clin Exp Allergy 1997 27 175 81
43. Depta JP Pichler WJ. Cross-reactivity with drugs at the T cell level Curr Opin Allergy Clin Immunol 2003 3 261 7
44. Shear N. Factive (gemifloxacin). FDA Advisory Committee Meeting March 4, 2003